Searched for
NATCO PHARMA SHARE BUYBACK
Global stocks: Shell pauses $3 billion share buybackShell has decided to put its $3 billion share repurchase program on hold from June 12 to July 14, as it navigates the implications of its a...- The accounting trick used by companies to make a weak balance sheet look strongIn one recent case, a large investment sat comfortably under equity until the auditor read the shareholders' agreement, found a buyback cla...
- Quant Small Cap Fund raises stake in Adani Enterprises and 8 others, trims in Aurobindo Pharma and 4 moreQuant Small Cap Fund increased exposure to Adani Enterprises and eight other stocks in May while reducing holdings in Aurobindo Pharma and ...
- 'Not a great environment for Indian market': Harsha Upadhyaya on Iran-US tensions, IT outlook, pharma bet, and where to be cautiousGlobal challenges are impacting Indian stocks. West Asian tensions and rising US inflation create headwinds. Tech sector shifts also affect...
- Sweet pills: How pharma stocks delivered bumper returns to Indian investors, defying 2026 whiplashIndian pharma stocks are outperforming the market, offering strong returns to investors. This resilience is driven by robust domestic deman...
- Wipro's Rs 15,000 crore buyback opens today: Analysts expect 7-8% returns for retail investors. Here's howWipro's significant Rs 15,000 crore share buyback has commenced. Eligible shareholders can tender shares at Rs 250, a substantial premium t...
- Zydus Lifesciences, 2 other share buybacks closing today. Are you participating?Investors have a final opportunity to tender shares in buyback offers from Zydus Lifesciences, Dhanuka Agritech, and CyberTech Systems and ...
- CMR Green Tech shares fall 8% after solid 43% stock market debut. Buy, sell or hold?CMR Green Technologies shares fell sharply from their post-listing highs after debuting at a 43% premium to the IPO price. While analysts r...
- Wipro's Rs 15,000 crore buyback opens tomorrow: 10 key things to know before tendering sharesWipro's substantial Rs 15,000 crore share buyback commences tomorrow, June 11, closing on June 17. Investors can tender shares at Rs 250 ea...
- Wipro's Rs 15,000 crore buyback opens tomorrow: Should retail investors tender shares?Wipro's Rs 15,000 crore share buyback opens on Thursday, offering shareholders an opportunity to tender their shares at Rs 250 apiece, a 38...
- Stocks in news: Emcure Pharma, Dixon Technologies, Ajanta Pharma, Godrej Properties, VedantaIndian markets experienced a volatile session, closing higher amidst mixed signals. Bulls are defending the 23,000 level in Nifty, but unce...
- Promoter sells Rs 1,024 crore worth of Ajanta Pharma shares in block deal to Kotak MF and ABSL MFA promoter entity of Ajanta Pharma sold shares worth over Rs 1,024 crore through a block deal, with Kotak Mahindra Mutual Fund and Aditya B...
- Wipro's Rs 15,000-crore buyback opens June 11; entitlement ratio and key details announcedIT major Wipro's Rs 15,000-crore share buyback offer will commence on June 11 and conclude on June 17, 2026. Small shareholders can tender ...
- Wipro shares plunge over 8%. What’s behind the selloff?Wipro shares dropped significantly on Monday. This decline follows the company's share buyback record date. Investors who bought shares for...
- Wipro plunges 8% after shares turn ex-record date for Rs 15,000 crore buybackWipro shares fell sharply on Friday after turning ex-record date for its Rs 15,000 crore buyback, despite broader market gains in the early...
- Wipro buyback alert! Last date to buy shares to participate in Rs 15,000 crore share buybackInvestors must purchase Wipro shares by today, June 4th, to be eligible for the company's Rs 15,000 crore share buyback, as Friday, June 5t...
- Alkem rolls out single-shot semaglutide syringes at Rs 350 for diabetes, weight lossAlkem Laboratories has launched semaglutide in single-shot pre-filled syringes in India. This makes treatment more accessible and affordabl...
- Natco Pharma shares crash 15% after weak Q4 results; net profit tanks 34% YoYNatco Pharma shares plunged after the company reported a steep fall in fourth-quarter profit, revenue and EBITDA. Weak operating margins an...
- Zydus Lifesciences hikes share buyback price to Rs 1,260 per share, lowers share countZydus Lifesciences increased its share buyback price to Rs 1,260 per share while reducing the repurchase size to 87.3 lakh shares. The tota...
- Zydus Lifesciences buyback alert! Last date to buy shares to participate in Rs 1,100 crore buyback at 7% premiumInvestors must purchase Zydus Lifesciences shares by Wednesday, May 27, to be eligible for the Rs 1,100 crore buyback, as the record date i...
Load More
